Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin alpha5beta1 is a major cellular receptor for fibronectin, playing a crucial role in cell adhesion, migration, and signaling. It mediates bidirectional signaling across the cell membrane, influencing cell behavior and fate. Overexpression of integrin alpha5beta1 is associated with aggressive cancer types, making it a therapeutic target for cancer treatment.
Integrin alpha5beta1 inhibitors block the interaction between the integrin and its ligands, such as fibronectin, thereby disrupting cell adhesion, migration, and signaling pathways involved in tumor growth and metastasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha5beta1 (ITGA5:ITGB1).